UnitedHealth Group (UNH) Rises Higher Than Market: Key Facts

UnitedHealth Group (UNH) closed at $353.72 in the latest trading session, marking a +1.56% move from the prior day. The stock's change was more than the S&P 500's daily gain of 0.06%. Meanwhile, the Dow gained 0.17%, and the Nasdaq, a tech-heavy index, added 0.39%. Shares of the largest U.S. health insurer witnessed a gain of 13.13% over the previous month, beating the performance of the Medical sector with its gain of 5.06%, and the S&P 500's gain of 3.94%.The upcoming earnings release of UnitedHealth Group will be of great interest to investors. The company's earnings report is expected on October 28, 2025. The company's earnings per share (EPS) are projected to be $2.87, reflecting a 59.86% decrease from the same quarter last year. In the meantime, our current consensus estimate forecasts the revenue to be $113.48 billion, indicating a 12.55% growth compared to the corresponding quarter of the prior year. UNH's full-year Zacks Consensus Estimates are calling for earnings of $16.21 per share and revenue of $448.78 billion. These results would represent year-over-year changes of -41.4% and +12.12%, respectively. It's also important for investors to be aware of any recent modifications to analyst estimates for UnitedHealth Group. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability. Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system. Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.82% lower. At present, UnitedHealth Group boasts a Zacks Rank of #4 (Sell). Investors should also note UnitedHealth Group's current valuation metrics, including its Forward P/E ratio of 21.49. This denotes a premium relative to the industry average Forward P/E of 14.52. We can also see that UNH currently has a PEG ratio of 2.25. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Medical - HMOs industry currently had an average PEG ratio of 1.45 as of yesterday's close. The Medical - HMOs industry is part of the Medical sector. This group has a Zacks Industry Rank of 223, putting it in the bottom 10% of all 250+ industries. The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions. Research Chief Names "Single Best Pick to Double"From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report UnitedHealth Group Incorporated (UNH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks